History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy
- 54 Downloads
Background and aims
Screening sigmoidoscopy can reduce incidence of colorectal cancer and mortality. The optimal re-screening interval has not yet been defined. This study is aimed at estimating the risk of distal advanced adenomas (diameter ≥10 mm, villous component >20%, high-grade dysplasia) and cancer at screening flexible sigmoidoscopy in subjects aged 55–64 years who reported pre-screening negative colorectal endoscopy.
Eight thousands two hundred two subjects aged 55–64 years who underwent screening flexible sigmoidoscopy within the SCORE trial in Italy and who were able to report their previous history of colorectal endoscopy.
Eight hundred eighty three of 8,202 subjects (10.8%) reported at least one prescreening negative endoscopy: among them, after 3–5 years, 6–10 years and >10 years intervals between last reported examination and screening endoscopy, the Absolute Risk of advanced adenomas was 1.5%, 0.9% and 0.9%; one cancer was detected (0.1%). Among the 7,319 subjects who did not report prescreening endoscopy the risks of advanced adenoma and cancer were 3.2% and 0.4%, respectively. Subjects with a previous colorectal examination had a 65% decreased risk of advanced adenomas (OR=0.35, 95%CI 0.18–0.66) and a 71% decreased risk of cancer (OR=0.29, 95%CI 0.04–1.12) as compared to those who did not. For subjects without family history of colorectal cancer the statistically significant decrease of the risk persisted up to ten years. The observed benefit seems not to apply to subjects with family history of colorectal cancer.
Our results are consistent with the hypothesis that the interval between screening sigmoidoscopies could be safely expanded beyond 5 years for subjects without specific risk factors for colorectal cancer.
The SCORE trial was supported by grants from the Italian Association for Cancer Research (AIRC 1995–97), the Italian National Research Council (CNR grant no. 95.00539.PF39 and no. 96.00736.PF39) Ministry of Public Health and the Istituto Oncologico Romagnolo (Rimini).
SOFAR s.p.a. provided the enema supply for the patients enrolled in the study.
- 2.Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents. IARC Sci Publ VII(143)Google Scholar
- 10.Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Shapiro M, Bond JH, Panish JF, Acrkroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET, The National Polyp Study Working Group (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329:1977–1981CrossRefPubMedGoogle Scholar
- 14.Selby JV, Friedman GD, Quesenberry CP, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 26:653–657Google Scholar
- 15.Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, Gastrointestinal Consortium Panel (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 124:544–560CrossRefPubMedGoogle Scholar
- 17.UK Flexible Sigmoidoscopy Screening Trial Investigators (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359:1291–1300Google Scholar
- 18.Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, Ferraris R, Gasperoni S, Penna A, Risio M, Rossini FP, Sciallero S, Zappa M, Atkin WS, SCORE Working Group–Italy (2002) Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy”—SCORE. J Natl Cancer Inst 94:1763–1772PubMedGoogle Scholar
- 19.Jass J, Sobin LH (1989) Histological typing of intestinal tumours, 2nd edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
- 20.Fleiss JL (1981) Statistical methods for rates and proportions, 2nd edn. Wiley, New York, NYGoogle Scholar
- 21.Schlesselman JJ (1982) Case-control studies. Design, conduct, analysis. Oxford University Press, New YorkGoogle Scholar
- 22.Norusis MJ (1992) SPSS for Windows, Professional Statistics, Release 5. SPSS Inc., ChicagoGoogle Scholar
- 26.Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, Marcus A, Ahnen D (2000) Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomark Prev 9:229–232Google Scholar
- 27.Yeazel MW, Church TR, Jones RM, Kochevar LK, Watt GD, Cordes JE, Engelhard D, Mongin SJ (2004) Colorectal cancer screening adherence in a general population. Cancer Epidemiol Biomark Prev 13:654–657Google Scholar
- 28.Seeff LC, Shapiro JA, Nadel MR (2002) Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral risk factor surveillance system. J Fam Pract 1:761–766Google Scholar
- 34.Gaburri M, Bassotti G, Bacci G, Cinti A, Bosso R, Ceccarelli P, Paolocci N, Pelli MA, Morelli A (1989) Functional gut disorders and health care seeking behaviour in an Italian non-patients population. Recent Prog Med 5:241–244Google Scholar
- 43.Yoshinaga M, Watabe R, Yanagisawa J, Harada N, Motomura S, Nawata H, Ikeda K (2001) The interval between flexible sigmoidoscopy examinations can be expanded beyond five years. Hepatogastroenterology 48:437–439Google Scholar